Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Universe Pharmaceuticals (UPC) Preferred Shares (2020 - 2025)

Historic Preferred Shares for Universe Pharmaceuticals (UPC) over the last 6 years, with Q3 2025 value amounting to $63009.6 billion.

  • Universe Pharmaceuticals' Preferred Shares rose 1697.74% to $63009.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $63009.6 billion, marking a year-over-year increase of 1697.74%. This contributed to the annual value of $63009.6 billion for FY2025, which is 1697.74% up from last year.
  • As of Q3 2025, Universe Pharmaceuticals' Preferred Shares stood at $63009.6 billion, which was up 1697.74% from $53864.7 billion recorded in Q3 2024.
  • Over the past 5 years, Universe Pharmaceuticals' Preferred Shares peaked at $63009.6 billion during Q3 2025, and registered a low of $29.3 million during Q1 2024.
  • In the last 5 years, Universe Pharmaceuticals' Preferred Shares had a median value of $29.3 million in 2022 and averaged $20879.1 billion.
  • In the last 5 years, Universe Pharmaceuticals' Preferred Shares tumbled by 9999.99% in 2022 and then surged by 18396939174.67% in 2024.
  • Quarter analysis of 5 years shows Universe Pharmaceuticals' Preferred Shares stood at $29279.2 billion in 2021, then plummeted by 100.0% to $29.3 million in 2022, then changed by 0.0% to $29.3 million in 2023, then soared by 183969391.75% to $53864.7 billion in 2024, then rose by 16.98% to $63009.6 billion in 2025.
  • Its Preferred Shares stands at $63009.6 billion for Q3 2025, versus $53864.7 billion for Q3 2024 and $29.3 million for Q1 2024.